News Despite study bust, Vistagen still hopes to file anxiety dru... Vistagen has chalked up another trial failure for fasedienol, its drug candidate for social anxiety disorder.
R&D Sponsored Beyond recruitment: Creating patient engagement that lasts In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Zoltan Varga discusses the importance of understanding patient motivations
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
